Verici Dx转发了
It was so great to see so much interest in mRNA signature biomarkers, including the One Lambda Pre-Transplant Risk Assessment (PTRA) Assay during our joint symposium with Verici Dx at this year’s Cutting Edge of Transplantation meeting. Our novel PTRA assay offers valuable information to assess a patient’s risk of early acute rejection and may allow for a more personalized approach to immunosuppression management. A big thank you to all our speakers, Dr. Zahraa Hajjiri, Dr. M. Javeed Ansari, Dr. Sanjeev Akkina and our moderator, Dr. Prince Anand for a thought provoking discussion on the utility of these gene expression assays! https://lnkd.in/gABEfk67 #CEoT #cuttingedgeinnovation #advanceddiagnostics #innovation Sara Barrington